Ambu A/S (LTS:0MJF)
kr 135.225 -0.875 (-0.64%) Market Cap: 36.39 Bil Enterprise Value: 36.63 Bil PE Ratio: 99.02 PB Ratio: 6.49 GF Score: 74/100

Ambu A/S at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2022 / 02:45PM GMT
Release Date Price: kr151.93 (-1.07%)
Craig Mcdowell
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, and good morning to everyone. My name is Craig Mcdowell. I'm a member of the equity research team at JPMorgan. Today, I'm very pleased to welcome Juan Jose Gonzalez, CEO of Ambu. Before I hand over to Juan Jose, just a reminder of the format for these sessions. We will first have around a 20-minute presentation from Jose after which, we will use the remainder of the time for Q&A. Investors are very welcome to ask questions to Juan Jose, which you can do using the Ask a Question button inference portal. With that, let me say thank you very much to Juan Jose. And let me hand over to you for your presentation.

Juan Jose Gonzalez;S;CEO;Member of Executive Board
Ambu A

/-&

Thank you very much, Craig, and hello, everyone. Let me spend a few minutes talking about single-use endoscopy market. Who we are as a company, our strategy, our progress on our key priorities, the performance and the outlook and what can you expect from us?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot